.GSK's long-acting breathing problem therapy has been presented to halve the number of attacks in a ...
.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has failed to bo...
.Matt Gline is back along with a brand-new 'vant' firm, after the Roivant Sciences chief executive o...
.Viridian Therapeutics' phase 3 thyroid eye illness (TED) clinical trial has reached its own major a...
.Along with a strong track record for identifying rough diamonds, Bain Funding Everyday Life Science...
.The latest decision to merge Genentech's 2 cancer cells departments was created "clinical causes," ...
.Terns Pharmaceuticals' decision to drop its liver health condition aspirations might yet repay, aft...
.Merck & Co.'s long-running initiative to land a blow on small cell lung cancer (SCLC) has actual...
.Some individuals with non-small cell lung cancer (NSCLC) possess mutations in a gene named individu...
.MBX has elaborated plans to enjoy over $136 thousand coming from its IPO as the biotech seeks to de...